Patents by Inventor Robert J. Sysko

Robert J. Sysko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5248699
    Abstract: This invention relates to a novel crystalline polymorphic form of sertraline hydrochloride, (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4 -tetrahydro-N-methyl-1-naphthalenamine hydrochloride, and to a method for preparing it.
    Type: Grant
    Filed: August 13, 1992
    Date of Patent: September 28, 1993
    Assignee: Pfizer Inc.
    Inventors: Robert J. Sysko, Douglas J. M. Allen
  • Patent number: 4940791
    Abstract: This invention relates to a process for the production of phthalazineacetic acid ester derivatives of the formula ##STR1## wherein R is (C.sub.1 -C.sub.4)alkyl which comprises reacting (Z)-3-oxo-1(3H)-isobenzofuranylideneacetic acid with hydrazine in the presence of a solvent; reacting the resulting mixture of the novel compound 1-hydrazino-1,2,3,4-tetrahydro-4-oxo-phthalazineacetic acid and 3,4-dihydro-4-oxo-phthalazineacetic acid with acid in the presence of a solvent; and reacting the resulting 3,4-dihydro-4-oxo-phthalazineacetic acid with acid in the presence of an alcohol.This invention also relates to the novel compound 1-hydrazino-1,2,3,4-tetrahydro-4-oxo-phthalazineacetic acid of the formula ##STR2## which is an intermediate formed in the process of this invention and which is useful for the production of phthalazineacetic acid ester derivatives of formula IV. The compounds of formula IV are useful for the preparation of certain heterocyclic oxophthalazinyl acetic acids and esters thereof.
    Type: Grant
    Filed: December 6, 1989
    Date of Patent: July 10, 1990
    Assignee: Pfizer Inc.
    Inventors: Terry G. Sinay, Jr., Robert J. Sysko
  • Patent number: 4904782
    Abstract: This invention relates to a process for the production of phthalazineacetic acid ester derivatives of the formula ##STR1## wherein R is (C.sub.1 -C.sub.4) alkyl which comprises reacting (Z)-3-oxo-1(3H)-isobenzofuranylideneacetic acid with hydrazine in the presence of a solvent; reacting the resulting mixture of the novel compound 1-hydrazino-1,2,3,4-tetrahydro-4-oxo-phthalazineacetic acid and 3,4-dihydro-4-oxo-phthalazineacetic acid with acid in the presence of a solvent; and reacting the resulting 3,4-dihydro-4-oxo-phthalazineacetic acid with acid in the presence of an alcohol.This invention also relates to the novel compound 1-hydrazino-1,2,3,4-tetrahydro-4-oxo-phthalazineacetic acid of the formula ##STR2## which is an intermediate formed in the process of this invention and which is useful for the production of phthalazineacetic acid ester derivatives of formula IV. The compounds of formula IV are useful for the preparation of certain heterocyclic oxophthalazinyl acetic acids and esters thereof.
    Type: Grant
    Filed: February 29, 1988
    Date of Patent: February 27, 1990
    Assignee: Pfizer Inc.
    Inventors: Terry G. Sinay, Jr., Robert J. Sysko
  • Patent number: 4360463
    Abstract: An improved process for making 6,6-diiodopenicillanic acid, an intermediate for preparation of 6-beta-iodopenicillanic acid, a beta-lactamase inhibitor, which comprises diazotizing 6-beta-aminopenicillanic acid in the presence of iodine, followed by washing the product of said process with an aqueous solution of an alkali metal iodide.
    Type: Grant
    Filed: September 2, 1981
    Date of Patent: November 23, 1982
    Assignee: Pfizer Inc.
    Inventor: Robert J. Sysko
  • Patent number: 4254250
    Abstract: Amine polymers are used to dewater suspensions of particulate matter in water. The polymers are synthesized by the reaction of a nitrile polymer such as polyacrylonitrile, an aminating agent, and a sulfur activator. The dewatering properties of these amine polymers can be beneficially employed to treat sewage sludge, silt laden water, industrial waste and the like.
    Type: Grant
    Filed: December 4, 1978
    Date of Patent: March 3, 1981
    Assignee: Pfizer Inc.
    Inventors: Raymond C. Glowaky, Steven R. Kurowsky, Robert J. Sysko